Chronic obstructive pulmonary disease (COPD) is a common respiratory condition involving the airways and characterized by airflow limitation. Gaseous and noxious particles play an important role in this process. Antioxidants are the substances that may protect cells from the damage caused by unstable molecules known as free radicals. The increased oxidative stress in patients with COPD is the result of an increased burden of inhaled oxidants, as well as increased amounts of reactive oxygen species (ROS) generated by various inflammatory, immune and epithelial cells of the airways. A total of 150 subjects with COPD and 100 healthy controls subjects were enrolled in this study from the period October 2015 to January 2016. The investigation included measurements of plasma superoxide dismutase activity (SOD), catalase activity (CAT), glutathione content (GSH) reduced form, (GPx) glutathione peroxidase, glutathione reductase (GR) and lipid peroxidation (LPO). Absorbance was measured by UV spectrophotometer. The estimated values of SOD, catalase, GPx, GSH and GR were found to be significantly (P = 0.0001) lower among the cases compared with controls. But, the levels of MDA were higher (P = 0.0001) in cases as compared to control group and there was significant difference in the oxidative stress parameters among the various stages of COPD. The post hoc analysis revealed that SOD was significantly (P < 0.01) lower among the mild, moderate and severe patients compared with very severe patients. The catalase was also observed to be significantly (P = 0.01) lower among mild, moderate and severe patients than very severe patients. The GPx was found to be significantly (P = 0.002) lower among the mild, moderate and severe patients compared with very severe patients. MDA was observed to be significantly higher in mild, moderate and severe patients compared with very severe (P = 0.001). GR was significantly (P = 0.003) lower among mild, moderate and severe patients than very severe patients. However, there was no significant difference in GSH among severity of COPD patients. This study suggests that oxidant and antioxidant imbalance plays an important role in various stages of severity of COPD. These results revealed the presence of an oxidative stress in subjects with COPD, and it is proportionate to the severity of disease.
Introduction
Chronic obstructive pulmonary disease (COPD) is a common clinical problem characterized by airflow obstruction that is irreversible or only partially reversible [1] . Oxidative stress has important implications on several events of lung physiology and for the pathogenesis of COPD. These include oxidative inactivation of antiproteases and surfactants, mucus hypersecretion, membrane lipid peroxidation, mitochondrial respiration, alveolar epithelial injury, remodelling of extracellular matrix and apoptosis. An increased level of reactive oxygen species (ROS) produced in the airways is reflected by increased markers of oxidative stress in the airspaces, sputum, breath, lungs and blood in patients with COPD, which is associated with the pathogenesis of several human diseases. The airflow obstruction in COPD is associated with abnormal inflammatory response of the lungs to chronic inhalational exposure from smoke, dust particles and other air pollutants [2] . It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries [3] . It is considered that ROS is the major cause of cell and tissue damage associated with many chronic inflammatory lung diseases, including COPD [4] [5] [6] . However, the precise mechanism of the aetiopathogenesis of COPD is not yet well defined. It is hypothesized that the increased oxidant burden and oxidant-antioxidant imbalance might be the main cause of the disease. Increased oxidative burden is generated from airway leucocytes in the blood or in air spaces directly as a result of cigarette smoke and environmental oxidant pollutants, and indirectly by the release of increasing amounts of ROS. The ROS are scavenged by antioxidant compounds and enzymes [5, 7] . Cigarette smoke is the main aetiological factor in the pathogenesis of COPD, as it leads to oxidant overload in the lower airways. Cigarette smoke contains more than 10 16 -10 17 oxidant molecules per puff and about 4700 chemicals, including peroxynitrite, superoxide radical and oxides of nitrogen [8] . The adverse contribution of cigarette smoke is considerable; however, the contribution of other risk factors is equally important, as all smokers do not develop COPD. Under normal conditions, the lungs and the blood are adequately protected by various extracellular and intracellular antioxidants against the deleterious effects of oxidants.
There is evidence to suggest an imbalance between oxidants and antioxidants in the lungs and the blood in smokers as well as in patients with COPD [9, 10] . Several reports have demonstrated the involvement of oxidative stress markers in the epithelial lining fluid, breath and urine of COPD patients, and a number of antioxidant abnormalities have been observed in patients with COPD [11] . Malondialdehyde (MDA) is the main product of lipid peroxidation (LPO), one of the key indicators of oxidative stress. These compounds are elevated in the sputum and exhaled breath condensate of COPD patients [12] . It has also been reported that abnormalities in antioxidants, such as reduced glutathione levels in the lungs, and lower antioxidant capacity of blood plasma were observed during COPD exacerbations [13] . Several researchers have reported that antioxidant abnormalities include decreased protein sulfhydryl and total antioxidant status in plasma as well as increased LPO products and elevated levels of F2-isoprostanes.
In this study, our aim was to confirm the hypothesis that oxidative stress plays a key role in COPD patients, leading to rapid decline in lung function. We had studied oxidant-antioxidant imbalance by measuring enzymatic antioxidants and correlated it with the degree of airflow obstruction.
Materials and methods
Study design and participants. This study is cross-sectional and conducted at tertiary care teaching hospital in North India. The final population recruited was formed fulfilling the inclusion and exclusion criteria.
Inclusion criteria:
(1) Diagnosed case of chronic obstructive pulmonary disease (2) Diagnosis were made by taking clinical histories of individuals, that is cough breathlessness, expectoration, dyspnoea and smoking status. (3) Spirometry was performed according to GOLD criteria (COPD was defined by a post-bronchodilator FEV1/FVC ratio < 0.70. COPD severity was determined by the GOLD criteria. Subjects with a post-bronchodilator FEV1/FVC ratio ≥ 0.70 were considered not to have COPD) in the study. Exclusion criteria:
(1) Patients with acute respiratory distress syndrome. (2) Serious systemic disorders incompatible with the study (either acute or chronic affecting any other target organ in the human body) (3) Patients with history of poorly controlled associated diseases such as heart disease, thyroid disorders, coagulation disorders and haematologic problems were excluded from the study (4) Patients were recruited from outdoor patients department of respiratory medicine. They had undergo a detailed questionnaire and after that spirometry was performed of every individual, and the patients were enrolled finally according to the GOLD criteria (in accordance with current GOLD guidelines (2012), COPD was defined by a postbronchodilator FEV1/FVC ratio < 0.70. COPD severity was determined by the GOLD criteria. Subjects with a post-bronchodilator FEV1/FVC ratio ≥ 0.70 were considered not to have COPD) in the study A total of 150 diagnosed cases of COPD patients fulfilling the inclusion and exclusion criteria from outdoor patients department by face-to-face conversation on demographics, smoking behaviours, physical measurements and medical history from the period October 2015 to January 2016 were recruited. The age criteria 30-60 years old were enrolled in the study. The study was approved by the corresponding institutional ethics committees, and all participants gave written informed consent. The criteria for diagnosis and severity of COPD were taken as per GOLD guidelines 2012. In accordance with current GOLD guidelines (2012), COPD was defined by a post-bronchodilator FEV1/FVC ratio < 0.70. COPD severity was determined by the GOLD criteria. Subjects with a postbronchodilator FEV1/FVC ratio ≥ 0.70 were considered not to have COPD.
A total of 100 healthy controls recruited from the general population, with no specific pulmonary disease, and none of them receiving any medication and specifically any inhaled bronchodilators or corticosteroids, participated in the study, where 45 were smokers and 55 were nonsmokers. The World Health Organization definition for smoker applied to the smokers who participated in the study. Fifty-five healthy non-smokers participated in this study as the control group and had no history of lung disease. All the participants in this study were selected using convenience sampling. All participants gave written informed consent. The age criteria were 25-60 years old. All participants classified as COPD and healthy controls were selected for the oxidative markers and antioxidants in blood lysate.
Sample collection. 5 ml of venous blood samples were collected from each patient and control subjects in heparinized vials and centrifuged it at 1,000 g for 15 min, and the plasma was removed. Then, erythrocytes were washed with 0.9% NaCl solution three times and kept at À80°C until biochemical determination.
Biochemical parameters.
(1) Assay of Catalase: The enzyme source is added to 2 ml of phosphate buffer and 1 ml of H 2 O 2 into a cuvette and mixed thoroughly. The decrease in absorbance at 240 nm were recorded after every 30 s for 3 min by following the method of Aebi [14] . (2) Assay of Superoxide dismutase: Carried out in two setups, the set recieved 0.3 ml nitro blue tetrazolium, 0.2 ml phenazine methosulphate, 1 ml pyrophosphate buffer, 1 ml triple-distilled water and 0.2 ml enzyme source. The second setup tube recieved all the above reagents minus the enzyme source. The reaction was started simultaneously by adding 0.1 ml NADH. After an interval of 90 s, 1 ml glacial acetic acid was added to each tube for checking the reaction. The absorbance was read at 560 nm against blank [15] . (3) Assay of Glutathione peroxidase: The reaction mixture consisting of 50 mM potassium phosphate buffer, EDTA (1 mM), NaN 3 (1 mM), NADPH (0.2 mM), GSSG-R (1 E.U) and GSH (1 mM) was setup in a total volume of 2.5 ml. Enzyme source was added to the above mixture and allowed to incubate for 5 min at room temperature. The reaction were initiated by adding H 2 O 2 (0.25 mM). Absorbance at 340 nm was recorded for 5 min after every 30 s interval [16] . (4) Glutathione reductase: The reaction mixture consist of 0.1 ml NADPH, 0.2 ml GSSG, 0.2 ml EDTA, 2.5 ml buffer and 0.1 ml blood lysate as enzyme source to a total volume of 3.0 ml. The reaction was initiated by the addition of NADPH. Oxidation of NADPH was followed at 340 nm. Blank reaction was also run simultaneously to correct the net changes in OD after NADPH auto-oxidation. The decrease in absorbance at 340 nm is followed at 30-s intervals. Protein content in the enzyme source was also determined. Enzyme unit was defined as nmole of NADPH oxidized per minute per mg protein.
The results were expressed as unit/min/mg protein [17] . (5) Reduced glutathione: Whole blood (1.0 ml) was deprotonized by adding 1.0 ml TCA and centrifuged at 6000 g for 5 min. 0.5 ml aliquot from supernatant was mixed with 0.5 ml double-distilled water. Thereafter, 2.0 ml of tris buffer and 0.1 ml DTNB solution were added to it by proper stirring. The absorbance was read at 912 nm on spectrophotometer with five times of the addition of GSH (200-1600 lmol) was drawn by the same procedure as describe above [18] . (6) Measurement of Lipid peroxide levels: The extent of per oxidation of lipid were evaluated on the basis of 2-thiobarbituric acid (TBA) with lipid peroxide, hydroperoxide and oxygen-labile double bond that gives rise to colour adducts with absorption maximum at 532 nm. A volume of 0.2 ml of plasma having about 3 mg protein was mixed with 0.5 ml of glacial acetic acid followed by the addition of 0.5 ml of 8% aqueous SDS (sodium dodecyl sulphate) and 1.5 ml of 0.8% TBA (thiobarbituric acid) solution. The reaction mixture were heated in a boiling water bath for 1 h. After cooling to room temperature, 3.0 ml of N-butanol was also be mixed and after thorough stirring for 5 min, the reaction mixture were centrifuged at 10,000 g for 15 min. A clear butanol fraction were obtained after centrifugation, absorbance of which were measured at 532 nm. Standard solution of malondialdehyde (10 nmol) was run simultaneously. Lipid peroxide content in the sample expressed as nmol of MDA/dl according to the method Ohkhawa and Ohishi [19] . Statistical analysis. The analysis was carried out using SPSS 16.0 version (SPSS Inc., Chicago, Illinois, USA). The results are presented in mean AE SD and percentages. The Kolmogorov test was used to test the pattern for normal distribution. The test showed non-normal pattern of these parameters. Hence, Kruskal-Wallis test followed by Tukey's post hoc comparison tests was used to compare the levels of SOD, catalase, GPX, GSH GR and LPO among different severity COPD and smoking habits. The P-value <0.05 was considered significant. Table 1 shows clinical characteristics of COPD patients, clinical characteristics of smoker and healthy control, and clinical characteristics of non-smoker and healthy control. Table 2 depicts a significant strong positive correlation was observed between post-FVC and pre-FVC (r = 0.95, P = 0.0001). Similarly, pre-FEV1 was found to be positively correlated with pre-FVC (r = 0.80, P = 0.0001) and post-FVC (r = 0.75, P = 0.0001). Post-FEV1 was also observed to be positively correlated with pre-FVC (r = 0.76, P = 0.0001), post-FVC (r = 0.75, P = 0.0001) and pre-FEV1 (r = 0.96, P = 0.0001). None of the oxidative stress parameters were correlated with spirometry parameters. Figure 1 shows the comparison of oxidative stress and antioxidant activity between cases and controls. The estimated values of SOD, catalase, GPX, GSH and GR were found to be significantly (P = 0.0001) lower among the cases compared with controls. But, the levels of MDA were higher (P = 0.0001) in cases as compared with control group. Figure 2 shows a significant difference in the oxidative stress and antioxidant parameters among mean concentration of superoxide dismutase, catalase, GSH peroxide, lipid peroxidase, glutathione and reduced glutathione in COPD patients (smoker and nonsmokers) and healthy control groups (smoker and nonsmokers). Figure 3 shows differences in antioxidants and oxidative stress markers according to GOLD categories (stage mild-very severe). We classified individuals according to post-FEV1% predicted by spirometry test. It also shows that there was significant difference in the oxidative stress parameters except GSH among severity of COPD. The post hoc analysis revealed that SOD, catalase, GPx and GR were significantly (P = 0.0001) lower among the mild, moderate and severe patients compared with very severe patients. However, there was no significant difference in GSH among severity of COPD patients. MDA was observed to be significantly higher in mild, moderate and severe patients compared with very severe (P = 0.0001).
Results

Discussion
It is well documented that increased oxidant or decreased antioxidant levels may reverse the physiological oxidantantioxidant balance in favour of oxidants. Oxidative stress may therefore play an important role in the pathogenesis of COPD. Our studies observed that patients with COPD noticeable increased oxidative stress, as shown by the higher levels of LPO products. This is accompanied by alterations in several endogenous enzymatic antioxidants in the blood plasma, including SOD, catalase, GSH, GR and GPx activity. According to analysed data, our result expressed an increased oxidative stress is most evident in patients with smoking compared with patients who do not smoke, and we find significant differences in lipid peroxidation and antioxidant status in smokers and nonsmoker patients in COPD and healthy control groups. These results also showed significantly (P = 0.0001) lowered antioxidant levels in SOD, catalase, GPX, GSH and GR in COPD patients when compared with healthy controls groups. But, the levels of MDA were higher (P = 0.0001) in cases as compared with healthy control group. It has been demonstrated that measures of oxidative stress and antioxidants, except GSH, differ significantly among COPD patients when grouped according to severity of COPD. In our study, we have seen that as the severity of disease increases, the levels of antioxidant parameters such as SOD, catalase, GPX, GSH and GR decreases, so we can conclude that the antioxidant markers are inversely proportional to severity of COPD. But in case of MDA, as the oxidative stress increases, the severity of disease also increases proportionally. Various studies have also reported increased plasma MDA levels in healthy smokers and in patients with COPD [20] . One of the most important lung diseases caused by cigarette smoking is COPD, which is an indicator of the amount of smoking in a country [21] . Chemically oxidative stress is associated with increased production of oxidizing species or a significant decrease in the effectiveness of antioxidant defences, such as glutathione [22] . Production of reactive oxygen species is a particularly destructive aspect of oxidative stress. Such species include free radicals and peroxides. Some of the less reactive of these species (such as superoxide) can be converted by oxidoreduction reactions with transition metals or other redox cycling compounds (including quinones) into more aggressive radical species that can cause extensive cellular damage [23] . Most long-term effects are caused by DNA damage [24] . Catalase is the major enzyme associated with hydrogen peroxide destruction, and is expressed in the intracellular alveolar macrophages, and neutrophil study depicts the comparison of oxidative stress and antioxidant activity between cases and controls. Previous studies have shown that there is oxidative stress in the lung and systemic circulation in COPD [20, 25] . The role of antioxidant defence Data were expressed in Mean AE SD.
Ó 2016 The Foundation for the Scandinavian Journal of Immunology Table 2 Spearman correlation coefficient between oxidative stress and spirometry parameters. Figure 1 Comparison of antioxidant/oxidant parameters between cases and controls. Ahmed et al. [6] observed a significant decrease in GPx activity in COPD patients; similar findings have previously been reported by Kluchova et al. [28] . This might be due to hydroxyl and superoxide anion, which plays a key role in the activation of red cell GPx [29] .
However, some studies demonstrated that antioxidant enzyme may be downregulated during severe or chronic oxidant exposure in an animal model [30] . Various studies have reported that the plasma levels of MDA are increased in healthy control and in patients with COPD [31, 32] . A study conducted by Birgul showed that MDA levels are significantly higher in smokers than in non-smokers [33] . Solak reported an increase in MDA levels and decrease in GPX activity in smokers, as compared with healthy nonsmokers [34] . Torres reported an increase in MDA levels in all stages of COPD severity, as compared with healthy controls [35] . Premanand reported elevated levels of MDA with concomitant reduction in GPX activity in respiratory diseases [36] . Nadeem reported an increase in MDA levels in COPD patients, as compared with healthy non-smoking controls. They found an increase in levels of SOD, catalase and GPX in severe COPD patients, as compared with moderate COPD patients [37] . Our correlation studies have observed that there was a significant strong positive correlation between post-FVC and pre-FVC. Similarly, pre-FEV1 was found to be positively correlated with pre-FVC and post-FVC. Post-FEV1 was also observed to be positively correlated with pre-FVC, post-FVC and pre-FEV1. But, none of the oxidative stress parameters were correlated with spirometry parameters.
Conclusion
The results of this study reinforce the evidence that oxidant/antioxidant imbalance is associated with airways obstruction. This study provides clear evidence for altered oxidant-antioxidant balance in COPD patients that increases in parallel with the severity of the disease. Further studies analysing the pathophysiological mechanisms involved in lung injury related to oxidant/antioxidant imbalance are required. Concentration (U/ml lysate) Figure 3 Comparison of oxidant-antioxidant status among COPD patients by disease severity.
